Physician profile
Alexander Farber Post
NPI 1750551123
$2,469.03
in general payments reported to CMS, 2019-2025
29 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $247 · 2021: $439 · 2022: $434 · 2023: $451 · 2024: $321 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $506.82 | 2022-2025 | Eterna, Proclaim |
| Medtronic, INC. | $350.94 | 2021-2025 | Pivox Oblique Lateral Spinal System, Plasmablade(Tm), Aquamantys(Tm) |
| Stryker Corporation | $188.25 | 2019-2023 | Vitoss |
| 4web, INC. | $144.09 | 2020 | |
| Aesculap, INC. | $132.90 | 2019-2021 | |
| Smith+Nephew, INC. | $126.15 | 2024 | Pico, Renasys Touch |
| Medacta USA, INC. | $100.20 | 2021 | |
| Leica Microsystems INC. | $91.16 | 2025 | |
| Spinal Elements, INC. | $88.46 | 2021 | |
| Boston Scientific Corporation | $75.28 | 2020-2023 | |
| Amgen INC. | $66.62 | 2020-2022 | |
| Misonix INC | $64.82 | 2021 | |
| Zap Surgical Systems, INC. | $63.25 | 2025 | Zap-X Treatment Delivery Software, Zap-X Radiosurgery System, Zap-X Mv Imager |
| Depuy Synthes Sales INC. | $57.44 | 2019 | |
| Alexion Pharmaceuticals, INC. | $52.41 | 2022-2023 | Ultomiris |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $47.79 | 2019-2023 | |
| Integra Lifesciences Corporation | $44.80 | 2020-2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Ethicon US, LLC | $37.80 | 2025 | Dermabond |
| Lemaitre Vascular, INC. | $34.69 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $25.41 | 2019 | |
| Baxter Healthcare | $24.15 | 2023 | Floseal |
| Jazz Pharmaceuticals INC. | $22.51 | 2022 | |
| Kuros Biosciences USA, INC | $21.89 | 2023 | |
| Nuvasive, INC. | $21.05 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.96 | 2025 | Thinflap |
| Takeda Pharmaceuticals U.S.A., INC. | $18.41 | 2024 | Hyqvia |
| Alnylam Pharmaceuticals INC. | $16.37 | 2023 | Onpattro |
| Nevro Corp. | $14.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Post listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.